Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

September 01, 1988; Volume 34,Issue 3
  • You have access
    Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
    W Young, J Chen, F Jung and P Gardner
    Molecular Pharmacology September 1988, 34 (3) 239-244;
  • You have access
    Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
    D M Tal and S J Karlish
    Molecular Pharmacology September 1988, 34 (3) 245-249;
  • You have access
    N-methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes: kinetic analysis.
    D W Bonhaus and J O McNamara
    Molecular Pharmacology September 1988, 34 (3) 250-255;
  • You have access
    Conversion of 5-hydroperoxyeicosatetraenoic acid into leukotriene B4 by rat hepatocytes: a novel cellular source for leukotriene B4.
    J Gut, D W Goldman and J R Trudell
    Molecular Pharmacology September 1988, 34 (3) 256-264;
  • You have access
    Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
    S L Wang, G W Lucier, R B Everson, G I Sunahara and K T Shiverick
    Molecular Pharmacology September 1988, 34 (3) 265-271;
  • You have access
    Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands.
    L Antkiewicz-Michaluk, A Guidotti and K E Krueger
    Molecular Pharmacology September 1988, 34 (3) 272-278;
  • You have access
    Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
    J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello
    Molecular Pharmacology September 1988, 34 (3) 279-285;
  • You have access
    Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures.
    H J Krause and R L Juliano
    Molecular Pharmacology September 1988, 34 (3) 286-297;
  • You have access
    Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
    T A Verdoorn and R Dingledine
    Molecular Pharmacology September 1988, 34 (3) 298-307;
  • You have access
    Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
    J A Clark, R Houghten and G W Pasternak
    Molecular Pharmacology September 1988, 34 (3) 308-317;
  • You have access
    Subclassification of beta-adrenergic receptors of rat fat cells: a re-evaluation.
    S W Bahouth and C C Malbon
    Molecular Pharmacology September 1988, 34 (3) 318-326;
  • You have access
    Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
    G R Luthin, J Harkness, R P Artymyshyn and B B Wolfe
    Molecular Pharmacology September 1988, 34 (3) 327-333;
  • You have access
    Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors.
    M Leid, M I Schimerlik and T F Murray
    Molecular Pharmacology September 1988, 34 (3) 334-339;
  • You have access
    Evidence for alpha 1-adrenergic receptor internalization in DDT1 MF-2 cells following exposure to agonists plus protein kinase C activators.
    M S Cowlen and M L Toews
    Molecular Pharmacology September 1988, 34 (3) 340-346;
  • You have access
    The potency and kinetics of the beta-adrenergic receptors on human neutrophils.
    H Mueller, H J Motulsky and L A Sklar
    Molecular Pharmacology September 1988, 34 (3) 347-353;
  • You have access
    Mechanism of gamma-aminobutyric acid/benzodiazepine receptor turnover in neuronal cells: evidence for nonlysosomal degradation.
    L A Borden and D H Farb
    Molecular Pharmacology September 1988, 34 (3) 354-362;
  • You have access
    Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
    G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman
    Molecular Pharmacology September 1988, 34 (3) 363-376;
  • You have access
    Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
    T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka
    Molecular Pharmacology September 1988, 34 (3) 377-387;
  • You have access
    The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
    E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito
    Molecular Pharmacology September 1988, 34 (3) 388-394;
  • You have access
    Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
    S Lenzen, S Freytag and U Panten
    Molecular Pharmacology September 1988, 34 (3) 395-400;
  • You have access
    Evidence for a copper:S-(methylthio)-L-homocysteine complex as a glutamine antagonist of cytidine triphosphate synthesis in L1210 murine leukemia cells.
    M Rabinovitz and J M Fisher
    Molecular Pharmacology September 1988, 34 (3) 401-406;
  • You have access
    Metabolism and excretion of S-conjugates derived from hexachlorobutadiene in the isolated perfused rat kidney.
    D Schrenk, W Dekant and D Henschler
    Molecular Pharmacology September 1988, 34 (3) 407-412;
  • You have access
    Effect of hypoxia on tert-butylhydroperoxide-induced oxidative injury in hepatocytes.
    D L Tribble, D P Jones and D E Edmondson
    Molecular Pharmacology September 1988, 34 (3) 413-420;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 34, Issue 3
1 Sep 1988
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics